Content:
- Company Overview of Krishna Institute of Medical Sciences Ltd
- Company Overview of Narayana Hrudayalaya Ltd
- The Stock Performance of Krishna Institute of Medical Sciences Limited
- The Stock Performance of Narayana Hrudayalaya Limited
- Fundamental Analysis of Krishna Institute of Medical Sciences Ltd
- Fundamental Analysis of Narayana Hrudayalaya
- Financial Comparison of Krishna Institute of Medical Sciences and Narayana Hrudayalaya
- Dividend of Krishna Institute of Medical Sciences and Narayana Hrudayalaya
- Advantages and Disadvantages of Investing in Krishna Institute of Medical Sciences
- Advantages and Disadvantages of Investing in Narayana Hrudayalaya
- How to Invest in Narayana Hrudayalaya and Krishna Institute of Medical Sciences Stocks?
- Krishna Institute of Medical Sciences vs. Narayana Hrudayalaya Limited- Conclusion
- Krishna Institute of Medical Sciences vs. Narayana Hrudayalaya – FAQ
Company Overview of Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd is an Indian company primarily focused on providing medical and healthcare services. The company offers a wide range of departments such as accident care, Alzheimer’s center, andrology and infertility center, pediatric obesity care, pediatric oncology and hematology center, and hepatobiliary surgery center.
Additionally, the company operates institutes specializing in Cardiac Sciences, Dental Science, Gastroenterology & Hepatology, Heart & Lung Transplantation, and Neuro Sciences.
Company Overview of Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Limited is an India-based healthcare provider that offers a range of medical services through a chain of multispecialty, tertiary, and primary healthcare facilities. The company is primarily involved in delivering medical and healthcare services and operates a network of multispecialty and super specialty hospitals at various locations.
It owns and manages several hospitals and provides services such as anesthesia, blood bank, stem cell transplant, breast cancer treatment, emergency medicine, endocrinology, family medicine, liver transplantation, and infectious disease treatment. With approximately 19 hospitals and three heart centers in India, as well as a presence in the Cayman Islands, the company has over 5,860 operational beds and a total capacity exceeding 6,160 beds.
The Stock Performance of Krishna Institute of Medical Sciences Limited
The table below displays the month-by-month stock performance of Krishna Institute of Medical Sciences Ltd for the past year.
Month | Return (%) |
Mar-2024 | -7.66 |
Apr-2024 | -1.26 |
May-2024 | -9.74 |
Jun-2024 | 10.81 |
Jul-2024 | 2.99 |
Aug-2024 | 17.61 |
Sep-2024 | -78.01 |
Oct-2024 | -2.7 |
Nov-2024 | 7.19 |
Dec-2024 | 1.53 |
Jan-2025 | 1.36 |
Feb-2025 | -14.47 |
The Stock Performance of Narayana Hrudayalaya Limited
The table below displays the month-by-month stock performance of Narayana Hrudayalaya Ltd for the past year.
Month | Return (%) |
Mar-2024 | -4.13 |
Apr-2024 | -0.42 |
May-2024 | -7.81 |
Jun-2024 | -1.25 |
Jul-2024 | 3.45 |
Aug-2024 | 0.33 |
Sep-2024 | -2.19 |
Oct-2024 | 1.74 |
Nov-2024 | 0.53 |
Dec-2024 | 0.22 |
Jan-2025 | 9.22 |
Feb-2025 | 4.75 |
Fundamental Analysis of Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd is a prominent healthcare organization based in India, known for its commitment to providing high-quality medical services. Established in 2004, the institute operates a multi-specialty hospital that offers a range of healthcare solutions, employing advanced medical technologies and skilled professionals. With a focus on patient care, the organization aims to meet the diverse health needs of the community.
The stock is currently priced at ₹570.55, with a market capitalization of ₹21,995.64 crore. It has delivered a 1-year return of 43.03%, though it saw a 1-month decline of 8.73%. The stock remains 18.18% below its 52-week high. The 5-year average net profit margin is 14.55%, reflecting stable profitability.
- Close Price ( ₹ ): 570.55
- Market Cap ( Cr ): 21995.64
- 1Y Return %: 43.03
- 6M Return %: 3.30
- 1M Return %: -8.73
- % Away From 52W High: 18.18
- 5Y Avg Net Profit Margin %: 14.55
Fundamental Analysis of Narayana Hrudayalaya
Narayana Hrudayalaya is a leading healthcare provider based in India, specializing in heart care and multidisciplinary healthcare services. Founded by Dr. Devi Prasad Shetty in 2000, the company operates a chain of hospitals and clinics across India and internationally. Narayana Hrudayalaya is known for its high-quality, affordable healthcare services, particularly in cardiology, orthopedics, and neurology.
The stock is currently priced at ₹1542.15, with a market capitalization of ₹31,951.67 crore. It has delivered a 1-year return of 29.85% and a 6-month return of 17.97%. The stock is 9.75% below its 52-week high, with a 5-year CAGR of 39.22% and a net profit margin of 8.22%, indicating strong profitability and growth. The dividend yield is 0.26%.
- Close Price ( ₹ ): 1542.15
- Market Cap ( Cr ): 31951.67
- Dividend Yield %: 0.26
- 1Y Return %: 29.85
- 6M Return %: 17.97
- 1M Return %: 12.95
- 5Y CAGR %: 39.22
- % Away From 52W High: 9.75
- 5Y Avg Net Profit Margin %: 8.22
Financial Comparison of Krishna Institute of Medical Sciences and Narayana Hrudayalaya
The table below shows a financial comparison of Krishna Institute of Medical Sciences Ltd and Narayana Hrudayalaya Ltd.
Stock | KIMS | NH | ||||
Financial type | FY 2023 | FY 2024 | TTM | FY 2023 | FY 2024 | TTM |
Total Revenue (₹ Cr) | 2238.38 | 2511.2 | 2903.10 | 4590.22 | 5093.44 | 5476.37 |
EBITDA (₹ Cr) | 651.45 | 660.76 | 774.80 | 1045.71 | 1242.53 | 1303.18 |
PBIT (₹ Cr) | 522.19 | 514.21 | 603.80 | 835.67 | 1000.39 | 1041.64 |
PBT (₹ Cr) | 484.91 | 459.64 | 523.90 | 751.58 | 888.53 | 907.89 |
Net Income (₹ Cr) | 336.33 | 310.14 | 348.20 | 606.25 | 789.27 | 783.62 |
EPS (₹) | 8.41 | 7.75 | 8.70 | 29.67 | 38.62 | 38.34 |
DPS (₹) | 0.0 | 0.0 | 0.00 | 2.5 | 4.0 | 4.00 |
Payout ratio (%) | 0.0 | 0.0 | 0.00 | 0.08 | 0.1 | 0.10 |
Points to be noted:
- (TTM) Trailing 12 Months – Trailing 12 months (TTM) is used to describe the past 12 consecutive months of a company’s performance data when reporting financial figures.
- EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization): Measures a company’s profitability before accounting for financial and non-cash expenses.
- PBIT (Profit Before Interest and Tax): Reflects operating profit by excluding interest and taxes from total revenue.
- PBT (Profit Before Tax): Indicates profit after deducting operating costs and interest but before taxes.
- Net Income: Represents the company’s total profit after all expenses, including taxes and interest, are deducted.
- EPS (Earnings Per Share): Shows the portion of a company’s profit allocated to each outstanding share of stock.
- DPS (Dividend Per Share): Reflects the total dividend paid out per share over a specific period.
- Payout Ratio: Measures the proportion of earnings distributed as dividends to shareholders.
Dividend of Krishna Institute of Medical Sciences and Narayana Hrudayalaya
Narayana Hrudayalaya has regularly rewarded shareholders, offering a ₹4 final dividend in 2024, reflecting its commitment to consistent payouts. In contrast, Krishna Institute of Medical Sciences has not issued any dividends yet. Check the table for complete details.
Narayana Hrudayalaya | |||
Announcement Date | Ex-Dividend Date | Dividend Type | Dividend (Rs) |
24 May, 2024 | 2 August, 2024 | Final | 4 |
19 May, 2023 | 7 July, 2023 | Final | 2.5 |
20 May, 2022 | 22 August, 2022 | Final | 1 |
27 February, 2020 | 11 March, 2020 | Interim | 1 |
24 May, 2019 | 1 August, 2019 | Final | 1 |
Advantages and Disadvantages of Investing in Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences Ltd
The primary advantage of Krishna Institute of Medical Sciences Ltd lies in its strong presence in the healthcare sector, offering comprehensive medical services across multiple specialties.
- Comprehensive Healthcare Services
Krishna Institute provides a wide range of healthcare services, including cardiology, orthopedics, and emergency care. This diverse offering helps the company attract a large customer base and maintain a steady revenue stream from various specialties. - Strong Regional Presence
The company has established a strong foothold in tier-2 and tier-3 cities, expanding its reach beyond metropolitan areas. This regional dominance allows it to cater to underserved populations, providing affordable healthcare in growing markets. - Focus on Medical Innovation
Krishna Institute is committed to adopting cutting-edge technology and innovative medical treatments. This focus on modernization ensures high-quality care and keeps the company competitive in the rapidly evolving healthcare industry. - Growing Demand for Healthcare
As India’s healthcare sector expands, especially due to increasing health awareness, Krishna Institute of Medical Sciences stands to benefit. The rising demand for healthcare services positions the company for long-term growth in the sector.
The main disadvantage of Krishna Institute of Medical Sciences Ltd is its heavy reliance on regional markets, which can limit its growth potential. With significant competition from larger healthcare players in urban areas, scaling operations while maintaining profitability becomes a challenge, especially in more saturated markets.
- Dependence on Regional Markets
Krishna Institute’s revenue is largely dependent on its presence in tier-2 and tier-3 cities. While these areas present growth opportunities, the company must overcome challenges related to limited patient volumes and competition from larger hospitals in urban centers. - High Operational Costs
Operating hospitals in multiple locations incurs high fixed costs, such as infrastructure, staff, and equipment. These operational expenses can impact the company’s profitability, especially when competing with larger, more resource-rich healthcare providers in the same regions. - Competition from Larger Healthcare Chains
Krishna Institute faces significant competition from established players like Fortis Healthcare and Apollo Hospitals, which have stronger brand recognition and more extensive resources. This competition makes it challenging to maintain pricing power and patient loyalty in certain markets. - Regulatory Risks
The healthcare industry is highly regulated, with strict rules regarding hospital accreditation, treatment standards, and pricing. Changes in government regulations or compliance failures could lead to fines, legal issues, or operational disruptions, affecting the company’s profitability. - Limited Brand Recognition Nationwide
While Krishna Institute is well-established in certain regions, it lacks the nationwide recognition of larger players in the healthcare industry. Expanding its brand presence across India requires significant investment in marketing, infrastructure, and service standardization to maintain consistent growth.
Advantages and Disadvantages of Investing in Narayana Hrudayalaya
Narayana Hrudayalaya Ltd
The primary advantage of Narayana Hrudayalaya Ltd is its established reputation in providing affordable, high-quality healthcare, especially in cardiac care. With a wide network of hospitals across India and international reach, the company benefits from rising healthcare demand, positioning itself for sustainable growth.
- Strong Brand in Cardiac Care
Narayana Hrudayalaya is recognized as a leader in cardiac care, specializing in heart surgeries. This expertise attracts patients seeking high-quality and affordable heart treatments, contributing significantly to its brand equity and revenue generation. - Wide Network of Hospitals
The company operates a large network of hospitals across India and internationally, making healthcare accessible in both urban and underserved areas. This widespread presence helps capture a larger patient base and supports consistent revenue growth. - Affordable Healthcare Model
Narayana Hrudayalaya focuses on providing cost-effective healthcare, especially in specialized areas like cardiology. This approach helps attract a broader demographic, making healthcare accessible to lower-income groups while maintaining profitability through efficient operational management. - Technological Advancements and Innovation
The company consistently invests in cutting-edge medical technologies and equipment. These innovations not only enhance the quality of patient care but also help the company stay competitive in a rapidly evolving healthcare sector, attracting more patients and increasing service efficiency. - Strong Management and Experienced Workforce
Narayana Hrudayalaya is led by an experienced team of healthcare professionals and executives. Their leadership ensures effective strategic decisions and smooth operations, fostering growth and enabling the company to expand its services both domestically and internationally.
The main disadvantage of Narayana Hrudayalaya Ltd is its heavy reliance on heart surgeries and specialized care. This focus on a niche market could limit growth opportunities, as it may not capture a broad range of patients or expand into other healthcare sectors as easily.
- Dependence on Cardiac Care
Narayana Hrudayalaya is known for its cardiac expertise, but this reliance on heart surgeries may limit its growth. If demand for cardiac services decreases or competitors advance in this field, it could impact revenue generation. - High Operating Costs
Operating hospitals, especially with specialized care, incurs high costs for equipment, skilled professionals, and patient care. These operational expenses can affect profitability, particularly if patient volumes fluctuate or if cost control measures are not effectively implemented. - Limited Diversification
While the company offers a variety of healthcare services, it is primarily focused on cardiology and specialized care. Expanding into other healthcare sectors such as general medicine, cancer care, or diagnostics could offer growth opportunities but may require significant investment. - Competition from Larger Healthcare Networks
Narayana Hrudayalaya faces intense competition from established healthcare providers like Apollo Hospitals and Fortis Healthcare. Competing with these larger networks in both patient volume and brand recognition can pose a challenge in sustaining long-term growth.
How to Invest in Narayana Hrudayalaya and Krishna Institute of Medical Sciences Stocks?
Suppose you’re interested in investing in Narayana Hrudayalaya and Krishna Institute of Medical Sciences Stocks. In that case, you can do so effortlessly through Alice Blue, which offers zero brokerage on equity delivery trades, allowing you to purchase stocks without any additional charges.
Step 1: Open a Demat & Trading Account
- Visit the Alice Blue website.
- Click on “Open Demat Account” and complete the registration process.
- Upload your PAN, Aadhaar, and bank details for verification.
Step 2: Fund Your Trading Account
- Log in to Alice Blue and navigate to the Funds section.
- Deposit money using UPI, Net Banking, or NEFT/RTGS for seamless transactions.
Step 3: Search & Analyze Narayana Hrudayalaya and Krishna Institute of Medical Sciences Stocks
- Use the search bar to find Narayana Hrudayalaya and Krishna Institute of Medical Sciences Stocks.
- Review the stock’s market price, charts, and company insights before making a decision.
Step 4: Place Your Buy Order
- Click “Buy” and select either a Market Order (instant purchase) or a Limit Order (buy at a specified price).
- Enter the quantity and confirm your order to complete the purchase.
Krishna Institute of Medical Sciences vs. Narayana Hrudayalaya Limited- Conclusion
Krishna Institute of Medical Sciences Ltd has a strong regional presence, focusing on providing affordable healthcare in tier-2 and tier-3 cities. However, it faces challenges in scaling operations beyond these regions and competing with larger healthcare chains. Growth depends on expanding its footprint and services.
Narayana Hrudayalaya Ltd is a leader in affordable heart care with a wide network of hospitals. Its expertise in cardiology and strong brand recognition provide significant growth potential. However, its focus on specialized services could limit broader market expansion and expose it to risks in this niche segment.
Krishna Institute of Medical Sciences vs. Narayana Hrudayalaya – FAQ
Krishna Institute of Medical Sciences Ltd is a prominent healthcare organization in India, offering a range of medical services, education, and research facilities. Established to provide quality healthcare, it operates hospitals, medical colleges, and specialized clinics, fostering medical excellence and innovation in patient care.
Narayana Hrudayalaya Ltd is a renowned healthcare organization based in India, specializing in cardiac care and advanced medical treatments. Founded by Dr. Devi Shetty, it operates numerous hospitals offering affordable and high-quality healthcare services, making significant contributions to the medical field both locally and internationally.
Healthcare stocks belong to companies that operate in the medical, pharmaceutical, biotechnology, and healthcare services industries. These stocks represent firms involved in healthcare products, services, and innovations, such as hospitals, drugs, medical equipment, and diagnostics. Healthcare stocks are considered stable investments due to the constant demand for healthcare services.
Dr. Abhinay Bollineni is the CEO of Krishna Institute of Medical Sciences Ltd (KIMS), having joined in 2013. Initially managing hospital operations, he later led strategy and marketing, becoming CEO in 2019.
The main competitors for Krishna Institute of Medical Sciences and Narayana Hrudayalaya include established healthcare providers like Apollo Hospitals, Fortis Healthcare, Max Healthcare, and Manipal Hospitals. These companies have extensive hospital networks, strong brand recognition, and advanced medical services, intensifying competition in the Indian healthcare sector.
As of March 2025, Narayana Hrudayalaya Ltd has a market capitalization of approximately ₹33,046 crore (₹330.46 billion). In comparison, Krishna Institute of Medical Sciences Ltd has a market capitalization of about ₹23,222 crore (₹232.22 billion). These figures indicate that Narayana Hrudayalaya’s market value surpasses that of Krishna Institute of Medical Sciences.
Krishna Institute of Medical Sciences is focusing on expanding its hospital network in both existing and new regions, particularly targeting tier-2 and tier-3 cities. The company is also investing in specialized medical services, improving digital healthcare platforms, and exploring international expansion to meet the growing demand for quality healthcare.
Narayana Hrudayalaya Limited is focusing on expanding its network of hospitals across India and internationally, particularly in cardiology and oncology. The company is investing in advanced medical technologies, improving affordable healthcare models, and exploring digital health services to enhance patient care and capture a larger market share.
Krishna Institute of Medical Sciences offers better dividends compared to Narayana Hrudayalaya. While both companies provide dividends to shareholders, Krishna Institute has a more consistent dividend payout history with slightly higher yields in recent years, making it a more attractive option for dividend-seeking investors.
Narayana Hrudayalaya Ltd has shown strong financial growth, with a market capitalization of approximately ₹33,490.65 crore and a 1-year return of about 32%. In contrast, Krishna Institute of Medical Sciences Ltd has a market cap around ₹23,214 crore, with a 3-year return of approximately 120.38%. Considering these factors, Narayana Hrudayalaya may be more favorable for long-term investors seeking growth and stability.
Krishna Institute of Medical Sciences generates most of its revenue from multi-specialty hospitals, particularly in cardiology, orthopedics, and oncology. Narayana Hrudayalaya derives significant revenue from its cardiology and oncology services, with a strong focus on affordable heart surgeries and specialized treatments, contributing to its dominant position in the healthcare sector.
Narayana Hrudayalaya Limited showed higher profitability than Krishna Institute of Medical Sciences, with a net profit margin of 15.7% for FY 2024, up from 13.4% last year. In comparison, Krishna Institute had a 12.1% margin, making Narayana more profitable.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.